Previous Article | Next Article 
Journal of Virology, January 2005, p. 536-546, Vol. 79, No. 1
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.1.536-546.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor
Sarah J. Paulsen,1
Mette M. Rosenkilde,2
Jesper Eugen-Olsen,1 and
Thomas N. Kledal1*
Clinical Research Unit, Copenhagen University Hospital, Hvidovre,1
Laboratory for Molecular Pharmacology, Department of Pharmacology, Panum Institute, University of Copenhagen, Copenhagen, Denmark2
Received 16 June 2004/
Accepted 30 August 2004
Both beta- and gammaherpesviruses encode G protein-coupled receptors (GPCRs) with unique pharmacological phenotypes and important biological functions. An example is ORF74, the
2-herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded GPCR, which is highly constitutively active and considered the key oncogene in Kaposi's sarcoma pathogenesis. In contrast, the current annotation of the Epstein-Barr virus (EBV) genome does not reveal any GPCR homolog encoded by this human oncogenic
1-herpesvirus. However, by employing bioinformatics, we recognized that the previously established EBV open reading frame BILF1 indeed encodes a GPCR. Additionally, BILF1 is a member of a new family of related GPCRs exclusively encoded by
1-herpesviruses. Expression of hemagglutinin-tagged BILF1 in the HEK293 epithelial cell line revealed that BILF1 is expressed as an approximately 50-kDa glycosylated protein. Immunocytochemistry and confocal microscopy revealed that BILF1 localizes predominantly to the plasma membrane, similar to the localization of KSHV ORF74. Using chimeric G proteins, we found that human and rhesus EBV-encoded BILF1 are highly potent constitutively active receptors, activating G
i. Furthermore, BILF1 is able to inhibit forskolin-triggered CREB activation via stimulation of endogenous G proteins in a pertussis toxin-sensitive manner, verifying that BILF1 signals constitutively through G
i. We suggest that EBV may use BILF1 to regulate G
i-activated pathways during viral lytic replication, thereby affecting disease progression.
* Corresponding author. Mailing address: Clinical Research Unit #136, H:S Hvidovre Hospital, Kettegaards Allé 30-31, 2650 Hvidovre, Denmark. Phone: 45 36322403. Fax: 45 36323797. E-mail: kledal{at}biobase.dk.
Journal of Virology, January 2005, p. 536-546, Vol. 79, No. 1
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.1.536-546.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Benned-Jensen, T., Rosenkilde, M. M.
(2008). Structural Motifs of Importance for the Constitutive Activity of the Orphan 7TM Receptor EBI2: Analysis of Receptor Activation in the Absence of an Agonist. Mol. Pharmacol.
74: 1008-1021
[Abstract]
[Full Text]
-
Boudry, C., Markine-Goriaynoff, N., Delforge, C., Springael, J.-Y., de Leval, L., Drion, P., Russell, G., Haig, D. M., Vanderplasschen, A. F., Dewals, B.
(2007). The A5 gene of alcelaphine herpesvirus 1 encodes a constitutively active G-protein-coupled receptor that is non-essential for the induction of malignant catarrhal fever in rabbits. J. Gen. Virol.
88: 3224-3233
[Abstract]
[Full Text]
-
Murph, M. M., Hurst-Kennedy, J., Newton, V., Brindley, D. N., Radhakrishna, H.
(2007). Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells. Mol Cancer Res
5: 1201-1211
[Abstract]
[Full Text]
-
Sharp, E. L., Farrell, H. E., Borchers, K., Holmes, E. C., Davis-Poynter, N. J.
(2007). Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates. J. Gen. Virol.
88: 2450-2462
[Abstract]
[Full Text]
-
Luttichau, H. R., Johnsen, A. H., Jurlander, J., Rosenkilde, M. M., Schwartz, T. W.
(2007). Kaposi Sarcoma-associated Herpes Virus Targets the Lymphotactin Receptor with Both a Broad Spectrum Antagonist vCCL2 and a Highly Selective and Potent Agonist vCCL3. J. Biol. Chem.
282: 17794-17805
[Abstract]
[Full Text]
-
Twizere, J.-C., Springael, J.-Y., Boxus, M., Burny, A., Dequiedt, F., Dewulf, J.-F., Duchateau, J., Portetelle, D., Urbain, P., Lint, C. V., Green, P. L., Mahieux, R., Parmentier, M., Willems, L., Kettmann, R.
(2007). Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood
109: 1051-1060
[Abstract]
[Full Text]
-
Hart, J., Ackermann, M., Jayawardane, G., Russell, G., Haig, D. M., Reid, H., Stewart, J. P.
(2007). Complete sequence and analysis of the ovine herpesvirus 2 genome. J. Gen. Virol.
88: 28-39
[Abstract]
[Full Text]
-
Sherrill, J. D., Miller, W. E.
(2006). G Protein-coupled Receptor (GPCR) Kinase 2 Regulates Agonist-independent Gq/11 Signaling from the Mouse Cytomegalovirus GPCR M33. J. Biol. Chem.
281: 39796-39805
[Abstract]
[Full Text]
-
Rosenkilde, M. M., Benned-Jensen, T., Andersen, H., Holst, P. J., Kledal, T. N., Luttichau, H. R., Larsen, J. K., Christensen, J. P., Schwartz, T. W.
(2006). Molecular Pharmacological Phenotyping of EBI2: AN ORPHAN SEVEN-TRANSMEMBRANE RECEPTOR WITH CONSTITUTIVE ACTIVITY. J. Biol. Chem.
281: 13199-13208
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.